Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Head and Neck Pathology|February 22, 2021
Myeloid Neoplasm with PDGFRA Rearrangement Manifesting as a Retromolar Pad MassAmy S Duffield, Jonathan Webster, B Douglas Smith, et al.
BMJ Leader|February 16, 2023
Embedding research (ER) led by nurses, midwives and allied health professionals (NMAHPs): the NMAHP-ER modelClaire Louise Whitehouse, Linda Tinkler, Carolyn Jackson, et al.
Bioorganic & Medicinal Chemistry|January 15, 2016
Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengersEmily Hofmann, Jonathan Webster, Thuy Do, et al.
The Annals of Pharmacotherapy|February 19, 2002
Brasofensine treatment for Parkinson's disease in combination with levodopa/carbidopaEdyta J Frackiewicz, Stanford S Jhee, Thomas M Shiovitz, et al.
Haematologica|March 20, 2025
Recognition, prevention, and management of adverse events associated with asparaginase / pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of an expert panelEmily Curran, Marlise R Luskin, Houda Alachkar, et al.
Scientific Reports|March 7, 2019
Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivoNicole D Vincelette, Husheng Ding, Amelia M Huehls, et al.
Haematologica|February 10, 2022
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and <i>BCR-ABL</i>-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicinSabine Kayser, Chiara Sartor, Marlise R Luskin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter studyJeffrey I Zwicker, Adam Rojan, Federico Campigotto, et al.
The Journal of Biological Chemistry|September 8, 2012
Chaperone activity of small heat shock proteins underlies therapeutic efficacy in experimental autoimmune encephalomyelitisMichael P Kurnellas, Sara E Brownell, Leon Su, et al.
Leukemia & Lymphoma|April 5, 2022
Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapyTheodoros Karantanos, Hua-Ling Tsai, Lukasz P Gondek, et al.
Pageof 5